Skip to main content
Psychedex

1Provenance card

the boundary, as counts

Sources

1912 with DOI

3 strong · 12 moderate · 4 weak

Compilations

12026-05-09T16:37:21.593Z

pipeline-v5 · prompt hash not recorded — run predates 2026-09

Decisions

31last ruled 2026-06-04

1 awaiting a ruling

Issued documents

42026-10-19T20:32:59.845Z

notice · info card · emergency

Searches

222 with no results

queries and counts on the build

Claims checked

6638 supported

38 supported · 28 not

Correspondence

0received

consent field ships in Phase 4

Edges

216

derivations recorded for this entity

Complete over 19 sources, 1 compilation, and 31 decisions.Not here: the private journal (never); 1 proposal awaiting a ruling (listed as pending only).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/metizolam/archive

Timeline

what happened, newest first — claims, searches and artifacts stay inside Build

  1. 2026-10-19issueIssued info_card
  2. 2026-10-02srcDesigner Benzodiazepines: A Review of Published Data and Public Health Significance
  3. 2026-10-02srcDetection of the designer benzodiazepine metizolam in urine and preliminary data on its metabolism
  4. 2026-10-02srcThe emergence of new psychoactive substance (NPS) benzodiazepines: A review.
  5. 2026-10-02srcThe use of a quantitative structure-activity relationship (QSAR) model to predict GABA-A receptor binding of newly emerging benzodiazepines
  6. 2026-10-02srcOccurrence and time course of NPS benzodiazepines in Sweden - results from intoxication cases in the STRIDA project.
  7. 2026-10-02srcThe Evolution Toward Designer Benzodiazepines in Drug-Facilitated Sexual Assault Cases
  8. 2026-10-02srcAdverse Events Associated with Flumazenil Treatment for the Management of Suspected Benzodiazepine Intoxication--A Systematic Review with Meta-Analyses.
  9. 2026-10-02srcDesigner benzodiazepines' pharmacological effects and potencies: How to find the information
  10. 2026-10-02srcValium without dependence? Individual GABAA receptor subtype contribution toward benzodiazepine addiction, tolerance, and therapeutic effects
  11. 2026-10-02src'New/Designer Benzodiazepines': An Analysis of the Literature and Psychonauts' Trip Reports
  12. 2026-10-02srcDesigner Benzodiazepines: A Review of Toxicology and Public Health Risks
  13. 2026-10-02srcA case of etizolam dependence
  14. 2026-10-02srcInhibition of the metabolism of etizolam by itraconazole in humans: evidence for the involvement of CYP3A4 in etizolam metabolism
  15. 2026-10-02srcInduction of the metabolism of etizolam by carbamazepine in humans
  16. 2026-10-02srcPharmacokinetics and pharmacodynamics of etizolam are influenced by polymorphic CYP2C19 activity
  17. 2026-10-02srcSingle and multiple dose pharmacokinetics of etizolam in healthy subjects
  18. 2026-10-02srcUK Misuse of Drugs Act 1971 (Amendment) Order 2017 No. 634
  19. 2026-10-02srcUS Patent 3904641A - Triazolothienodiazepine compounds
  20. 2026-10-02srcMetizolam - HandWiki (Chemistry)
  21. 2026-09-04issueIssued emergency
  22. 2026-09-04issueIssued info_card
  23. 2026-09-04issueIssued notice
  24. 2026-07-03proposaldependence · taper
  25. 2026-06-04proposal28 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
  26. 2026-06-04publicationPublication — backfill
  27. 2026-05-09revisionRevision 1
  28. 2026-05-09absenceSearched PubMed for "metizolam thienodiazepine pharmacology" — no results
  29. 2026-05-09absenceSearched ClinicalTrials.gov for "metizolam" — no results
  30. 2026-05-09genGeneration — pipeline-v5 · with 4 morepipeline-v5
  31. 2026-05-09rungeneration run

The same entries, as forms: six forms.